» Articles » PMID: 22269007

Identification of a Novel HIV Type 1 Circulating Recombinant Form (CRF52_01B) in Southeast Asia

Overview
Publisher Mary Ann Liebert
Date 2012 Jan 25
PMID 22269007
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Thirty HIV-1 URF_01AE/ B' complete or nearly full-length genome sequences sampled within Southeast Asia were obtained from the Los Alamos HIV Sequence Database. Phylogenetic and recombinant analyses revealed that three sequences indeed displayed the identical recombinant structure. Of note, the three subjects, harboring novel CRF01_AE/B recombinants, did not have apparent epidemiological linkage. They fulfilled the criteria for the designation of a new circulating recombinant form (CRF) and constituted the 52nd CRF identified in the worldwide HIV-1 pandemic. In this chimera, two short subtype B segments were inserted into a backbone of CRF_01AE. The breakpoints corresponded to HXB2 nucleotide positions 2930, 3251, 8521, and 9004 approximately. This CRF is the first one identified by neatening and analyzing the sequences already presented in the Los Alamos HIV Sequence Database. This indicates that we should pay attention not only to explicit subtype sequences but also to those classified as a unique recombinant form (URF) so far.

Citing Articles

Identification of two novel HIV-1 circulating recombinant forms of CRF111_01C and CRF116_0108 in southwestern Yunnan, China.

Ye M, Chen X, Duo L, Ma J, Cao L, Zhang C Virulence. 2021; 13(1):19-29.

PMID: 34951549 PMC: 9794008. DOI: 10.1080/21505594.2021.2010399.


Extensive Genetic Diversity of HIV-1 in Incident and Prevalent Infections among Malaysian Blood Donors: Multiple Introductions of HIV-1 Genotypes from Highly Prevalent Countries.

Chow W, Bon A, Keating S, Anderios F, Halim H, Takebe Y PLoS One. 2016; 11(8):e0161853.

PMID: 27575746 PMC: 5004849. DOI: 10.1371/journal.pone.0161853.


A Large-scale Survey of CRF55_01B from Men-Who-Have-Sex-with-Men in China: implying the Evolutionary History and Public Health Impact.

Han X, Takebe Y, Zhang W, An M, Zhao B, Hu Q Sci Rep. 2015; 5:18147.

PMID: 26667846 PMC: 4678862. DOI: 10.1038/srep18147.


HIV-1 CRF01_AE and Subtype B Transmission Networks Crossover: A New AE/B Recombinant Identified in Japan.

Hosaka M, Fujisaki S, Masakane A, Hattori J, Shiino T, Gatanaga H AIDS Res Hum Retroviruses. 2015; 32(5):412-9.

PMID: 26571151 PMC: 4845645. DOI: 10.1089/aid.2015.0192.


Genome Sequence of Complex HIV-1 Unique Recombinant Forms Sharing a Common Recombination Breakpoint Identified in Malaysia.

Cheong H, Ng K, Ong L, Takebe Y, Chan K, Koh C Genome Announc. 2015; 3(6).

PMID: 26543107 PMC: 4645192. DOI: 10.1128/genomeA.01220-15.


References
1.
Watanaveeradej V, Benenson M, de Souza M, Sirisopana N, Nitayaphan S, Tontichaivanich C . Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping. AIDS Res Hum Retroviruses. 2006; 22(8):801-7. DOI: 10.1089/aid.2006.22.801. View

2.
Yang R, Xia X, Kusagawa S, Zhang C, Ben K, Takebe Y . On-going generation of multiple forms of HIV-1 intersubtype recombinants in the Yunnan Province of China. AIDS. 2002; 16(10):1401-7. DOI: 10.1097/00002030-200207050-00012. View

3.
Xu F, Kilmarx P, Supawitkul S, Yanpaisarn S, Limpakarnjanarat K, Manopaiboon C . HIV-1 seroprevalence, risk factors, and preventive behaviors among women in northern Thailand. J Acquir Immune Defic Syndr. 2000; 25(4):353-9. DOI: 10.1097/00042560-200012010-00010. View

4.
Tee K, Li X, Nohtomi K, Ng K, Kamarulzaman A, Takebe Y . Identification of a novel circulating recombinant form (CRF33_01B) disseminating widely among various risk populations in Kuala Lumpur, Malaysia. J Acquir Immune Defic Syndr. 2006; 43(5):523-9. DOI: 10.1097/01.qai.0000242451.74779.a7. View

5.
Kalish M, Baldwin A, Raktham S, Wasi C, Luo C, Schochetman G . The evolving molecular epidemiology of HIV-1 envelope subtypes in injecting drug users in Bangkok, Thailand: implications for HIV vaccine trials. AIDS. 1995; 9(8):851-7. DOI: 10.1097/00002030-199508000-00004. View